Dec. 5 -- (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you are 18 or older, are scheduled to receive an autologous or allogeneic hematopoietic cell transplant within 60 days, have hematologic malignancy -- or are receiving chemotherapy for breast, colorectal, or lung malignancy -- you may be eligible for this study.
The research site is in South Granville, Wash.
If you are 18 or older with a confirmed diagnosis of malignant pleural mesothelioma, and have failed prior chemotherapy that included pemetrexed with either cisplatin or carboplatin, you may qualify for this study.
The research site is in Pittsburgh, Penn.
If you are at least 18 and have been diagnosed with advanced cancer of the lining of the uterus, you may be eligible for this study.
The research site is in Jamaica, N.Y.
Copyright 2008 CenterWatch. All rights reserved.